Trial
NCT01954524
A Phase 1, Open-Label Study of Intravenous Sildenafil in Patients With Cirrhosis
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
University of Maryland, Baltimore
Collaborators
—
Condition
Cirrhosis
Intervention
IV bolus injection of Sildenafil
Why stopped
The study is closed due to lack of funding to support the study.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2022-11-15